Alliancebernstein L.P. Concert Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$3.77 - $5.24 $151,931 - $211,172	-40,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.8 - $11.52 $33,540 - $49,536	4,300 Added 11.94%	40,300 $401,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $82,128 - $114,144	8,700 Added 31.87%	36,000 $432,000
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $22,933 - $33,326	1,900 Added 7.48%	27,300 $330,000
Q4 2018 Feb 13, 2019	BUY	$11.25 - $16.17 $23,625 - $33,957	2,100 Added 9.01%	25,400 $319,000
Q3 2018 Nov 08, 2018	BUY	$12.82 - $17.88 $15,384 - $21,456	1,200 Added 5.43%	23,300 $346,000
Q2 2018 Aug 13, 2018	BUY	$16.83 - $21.66 $74,051 - $95,304	4,400 Added 24.86%	22,100 $372,000
Q1 2018 May 14, 2018	BUY	$19.24 - $28.03 $75,036 - $109,317	3,900 Added 28.26%	17,700 $405,000
Q4 2017 Feb 13, 2018	BUY	$13.96 - $29.05 $18,148 - $37,765	1,300 Added 10.4%	13,800 $357,000
Q3 2017 Nov 13, 2017	BUY	$13.91 - $15.31 $173,875 - $191,375	12,500	12,500 $184,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.